$IBM

IBM Stock Wavers After-Hours Amid Revenue Miss, Lower 2026 Outlook — AI Demand Remains Strong, Says Company

IBM reported Q2 revenue of $17.16B, missing estimates, with infrastructure sales down 7%. It lowered its 2026 revenue outlook to 4-5% growth. Shares fluctuated after-hours, initially up 3% before edging lower. Adjusted earnings matched expectations at $2.93 per share.

Original reporting
Published Aug 29, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 30, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IBM
Bearish
high confidence
Mentioned
$IBM
Relevance
8/10
AlphAI data visualization · based on stocktwits.com
Decision brief

The 30-second read

$IBMBearishHigh
01

Why it matters

The earnings miss and guidance reduction are likely to trigger short‑term selling pressure, though the company's AI positioning may support longer‑term upside.

02

Market read

IBM's earnings and outlook revision are material for investors and can affect related tech and AI infrastructure stocks.

03

What to watch

IBM's recurring software revenue and mainframe stability could provide a revenue floor not fully reflected in the price.

Relevance 8/10Novelty 8/10Timing: after‑hours

Background

IBM announced Q2 results with a slight revenue beat on a 1% YoY increase but missed consensus, and lowered its full‑year 2026 revenue growth to 4‑5% from >5%.

Company-level read

Ticker impact

$IBMBearishHigh confidence
Context

IBM reported Q2 revenue miss and cut its 2026 sales outlook, prompting after‑hours price movement.

Expected impact

Potential downside of 3‑5% over the next few days as investors reassess growth expectations.

Evidence & confidence

Revenue fell short of estimates and guidance was reduced, a material change for a large‑cap tech company.

Market effects

Softening outlook may weigh on the broader enterprise‑software and infrastructure sector.

U.S. tech stocks could see modest pullback in the near term.

IBM's guidance cut could influence global AI‑infrastructure spending sentiment.

Counterpoint

If AI demand accelerates faster than expected, the guidance cut may be overly cautious, presenting a buying opportunity.

Key entities

  • IBM

    International Business Machines Corp., a U.S. listed technology firm.

  • Arvind Krishna

    IBM Chairman, President and CEO who commented on AI-driven future.

Related articles

$MSFTMed

Sars to pay Microsoft and IBM R2.75-billion in sole-source deals

South African Revenue Service (Sars) awarded Microsoft and IBM contracts worth R2.75 billion for software, hardware, and support services over three years, approved without open tenders. Microsoft's deal is valued at R1.58 billion, while IBM's is R1.17 billion. Sars also deployed AI tools, including Microsoft Copilot, and reported handling millions of digital queries. Sars faces underfunding risks and is exploring alternative funding models for modernization.

$IBMMed

Wall Street analyst sets IBM stock price for 12 months

Truist Securities analyst Arvind Ramnani initiated a 'Hold' rating for IBM (NYSE: IBM) with a 12-month price target of $240, implying a 6.37% upside from its current price of $225.63. The bullish outlook is based on IBM's strong positioning in key domains, but risks include operational execution and AI infrastructure adoption timelines. TipRanks reports an average price target of $250.45 from 20 analysts, suggesting an 11% potential uptick.

$IBMMed

IBM and SAP Team Up to Support Cloud ERP Modernization for Mid-Sized Enterprises, Offering End-to-End AI Infrastructure Development

IBM and SAP launched 'IBM Ready for SAP Solutions' to aid mid-sized firms in cloud ERP migration, combining SAP's platform with IBM's consulting. Early adopters reported efficiency gains. IBM aims to capitalize on SAP's 2027 maintenance deadline, despite recent financial struggles. IBM's stock is down 25% YTD, with analysts divided on its outlook.

$IBMHighAI 8/10

Truist starts IBM at Hold, says AI demand timing is the key question

Truist initiated coverage of IBM with a Hold rating and $240 price target, citing long-term potential in enterprise computing but near-term execution risks. IBM's Q2 miss was attributed to timing and budget shifts, leading to a 20% stock drop. Software revenue grew 8%, but deferred contracts impacted guidance. Analysts see upside potential if deferred deals close and software growth improves.